在上海接受CAR-T治疗后, 一名患有晚期癌症的新西兰男子获得缓解, 这凸显了中国在全球癌症治疗中不断提升的作用。 A New Zealand man with advanced cancer went into remission after receiving CAR-T therapy in Shanghai, highlighting China’s rising role in global cancer treatment.

在上海国际癌症中心(Jiahui国际癌症中心)接受CAR-T治疗后, 一名78岁的新西兰男子复发后患上多种骨髓瘤, 获得完全治疗, A 78-year-old New Zealand man with relapsed multiple myeloma achieved complete remission after receiving CAR-T therapy at Shanghai’s Jiahui International Cancer Center, marking a milestone in its growing role as a global hub for advanced cancer care. 在家施用精疲力竭的治疗后,经过远程咨询,他行走9 000多公里,9月收获T细胞,10月注入,数周内没有发现任何可检测的疾病。 After exhausting treatments at home, he traveled over 9,000 kilometers following a remote consultation, underwent T-cell harvesting in September and infusion in October, and showed no detectable disease within weeks. 病人赞扬了医院的快速诊断、高效护理和支助人员。 The patient praised the hospital’s rapid diagnostics, efficient care, and supportive staff. JICC是上海第一所国际三级医院的一部分,与马萨诸塞总医院合作,在2025年治疗了24 000名国际病人,包括35名医疗旅游病人,因为中国在CAR-T试验和病人数量方面位居全球第二。 JICC, part of Shanghai’s first international tertiary hospital and partnered with Massachusetts General Hospital, treated 24,000 international patients in 2025, including 35 for medical tourism, as China ranks second globally in CAR-T trials and patient volume.